Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ORPHAN DRUG AMENDMENTS WOULD BE VETOED BY PRESIDENT BUSH, FDA TELLS SENATE; SEN. HATCH SAYS ORPHAN ACT SHOULD NOT BE USED TO REMEDY FINANCIAL ACCESS
Mar 09 1992
•
By
The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Archive
More from Pink Sheet